What's in Universidad de Valparaiso's pipeline?

Universidad de Valparaiso has 3 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 2 in Phase 1.

Which companies overlap with Universidad de Valparaiso's portfolio?

Top competitors by shared drug class: Beijing Minhai Biotechnology Co., Ltd, Bharat Biotech International Limited, BioNTech, Boryung Pharmaceutical Co., Ltd, CanSino Biologics Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/universidad-de-valparaiso.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Universidad de Valparaiso — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Universidad de Valparaiso pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Recombinant Hepatitis B Virus Vaccine	Recombinant Hepatitis B Virus Vaccine	phase 3	Vaccine		Immunology

Therapeutic area mix

Immunology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Beijing Minhai Biotechnology Co., Ltd · 1 shared drug class
Bharat Biotech International Limited · 1 shared drug class
BioNTech · 1 shared drug class
Boryung Pharmaceutical Co., Ltd · 1 shared drug class
CanSino Biologics Inc. · 1 shared drug class
Centre for Infectious Disease Research in Zambia · 1 shared drug class
Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno · 1 shared drug class
Arcturus Therapeutics, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Universidad de Valparaiso:

Cite this brief

Drug Landscape (2026). Universidad de Valparaiso — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/universidad-de-valparaiso. Accessed 2026-05-17.